Fu Yang

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Topics

Long Non Coding Rna

Postmenopausal Women

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

British journal of cancer

Signal transduction and targeted therapy

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zheng Zhang, Yichen Meng, Tao Lin, Zhanrong Zhang, Zhengbo Tao, Hao-Zan Yin, Fu Yang, Xuhui Zhou
Dancr-BRG1 regulates Nfatc1 transcription and Pgc1β-dependent metabolic shifts in osteoclastogenesis. Proceedings of the National Academy of Sciences of the United States of America 121 (5) (2024)
Bang Xiao, Yiqing Zhu, Meng Liu, Meiting Chen, Chao Huang, Dabing Xu, Fang Wang, Shuhan Sun, Jinfeng Huang, Ningxia Sun, Fu Yang
miR-340-3p-modified bone marrow mesenchymal stem cell-derived exosomes inhibit ferroptosis through METTL3-mediated m 6 A modification of HMOX1 to promote recovery of injured rat uterus. Stem cell research & therapy 15 (1) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Zheng Zhang, Yichen Meng, Tao Lin, Zhanrong Zhang, Zhengbo Tao, Hao-Zan Yin, Fu Yang, Xuhui Zhou
Dancr-BRG1 regulates Nfatc1 transcription and Pgc1β-dependent metabolic shifts in osteoclastogenesis. Proceedings of the National Academy of Sciences of the United States of America 121 (5) (2024)
Zheng Zhang, Yichen Meng, Tao Lin, Zhanrong Zhang, Zhengbo Tao, Hao-Zan Yin, Fu Yang, Xuhui Zhou
Dancr-BRG1 regulates Nfatc1 transcription and Pgc1β-dependent metabolic shifts in osteoclastogenesis. Proceedings of the National Academy of Sciences of the United States of America 121 (5) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Zhihui Dai, Sijie Wang, Xinggang Guo, Yuefan Wang, Haozan Yin, Jian Tan, Chenyang Mu, Shu-Han Sun, Hui Liu, Fu Yang
Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST. Clinical and translational medicine 13 (12) (2024)
Zhihui Dai, Sijie Wang, Xinggang Guo, Yuefan Wang, Haozan Yin, Jian Tan, Chenyang Mu, Shu-Han Sun, Hui Liu, Fu Yang
Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST. Clinical and translational medicine 13 (12) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Bang Xiao, Yiqing Zhu, Meng Liu, Meiting Chen, Chao Huang, Dabing Xu, Fang Wang, Shuhan Sun, Jinfeng Huang, Ningxia Sun, Fu Yang
miR-340-3p-modified bone marrow mesenchymal stem cell-derived exosomes inhibit ferroptosis through METTL3-mediated m 6 A modification of HMOX1 to promote recovery of injured rat uterus. Stem cell research & therapy 15 (1) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Bang Xiao, Yiqing Zhu, Meng Liu, Meiting Chen, Chao Huang, Dabing Xu, Fang Wang, Shuhan Sun, Jinfeng Huang, Ningxia Sun, Fu Yang
miR-340-3p-modified bone marrow mesenchymal stem cell-derived exosomes inhibit ferroptosis through METTL3-mediated m 6 A modification of HMOX1 to promote recovery of injured rat uterus. Stem cell research & therapy 15 (1) (2024)
Zheng Zhang, Yichen Meng, Tao Lin, Zhanrong Zhang, Zhengbo Tao, Hao-Zan Yin, Fu Yang, Xuhui Zhou
Dancr-BRG1 regulates Nfatc1 transcription and Pgc1β-dependent metabolic shifts in osteoclastogenesis. Proceedings of the National Academy of Sciences of the United States of America 121 (5) (2024)
Zheng Zhang, Yichen Meng, Tao Lin, Zhanrong Zhang, Zhengbo Tao, Hao-Zan Yin, Fu Yang, Xuhui Zhou
Dancr-BRG1 regulates Nfatc1 transcription and Pgc1β-dependent metabolic shifts in osteoclastogenesis. Proceedings of the National Academy of Sciences of the United States of America 121 (5) (2024)
Jian Tan, Yue-Fan Wang, Zhi-Hui Dai, Hao-Zan Yin, Chen-Yang Mu, Si-Jie Wang, Fu Yang
Roles of RNA m6A modification in nonalcoholic fatty liver disease. Hepatology communications 7 (2) (2023)
Zhihui Dai, Sijie Wang, Xinggang Guo, Yuefan Wang, Haozan Yin, Jian Tan, Chenyang Mu, Shu-Han Sun, Hui Liu, Fu Yang
Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST. Clinical and translational medicine 13 (12) (2023)
Jian Tan, Yue-Fan Wang, Zhi-Hui Dai, Hao-Zan Yin, Chen-Yang Mu, Si-Jie Wang, Fu Yang
Roles of RNA m6A modification in nonalcoholic fatty liver disease. Hepatology communications 7 (2) (2023)
Jian Tan, Yue-Fan Wang, Zhi-Hui Dai, Hao-Zan Yin, Chen-Yang Mu, Si-Jie Wang, Fu Yang
Roles of RNA m6A modification in nonalcoholic fatty liver disease. Hepatology communications 7 (2) (2023)
Jian Yu, Wen Li, Guo-Jun Hou, Da-Peng Sun, Yuan Yang, Sheng-Xian Yuan, Zhi-Hui Dai, Hao-Zan Yin, Shu-Han Sun, Gang Huang, Wei-Ping Zhou, Fu Yang
Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation. Experimental & molecular medicine (2023)
Zhihui Dai, Sijie Wang, Xinggang Guo, Yuefan Wang, Haozan Yin, Jian Tan, Chenyang Mu, Shu-Han Sun, Hui Liu, Fu Yang
Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST. Clinical and translational medicine 13 (12) (2023)
Jie Li, Yiqing Zhu, Zhenxia Ma, Fu Yang
Genome sequence and pathogenicity of Vibrio vulnificus strain MCCC 1A08743 isolated from contaminated prawns. Biology open 11 (6) (2022)
Dapeng Sun, Xiaojie Gan, Lei Liu, Yuan Yang, Dongyang Ding, Wen Li, Junyao Jiang, Wenbin Ding, Linghao Zhao, Guojun Hou, Jian Yu, Jie Wang, Fu Yang, Sheng-Xian Yuan, Wei-Ping Zhou
DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334. Cell death & disease 13 (5) (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer 128 (5) (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer 128 (5) (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer 128 (5) (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer 128 (5) (2022)
Jian Yu, Wei-Long Huang, Qing-Guo Xu, Ling Zhang, Shu-Han Sun, Wei-Ping Zhou, Fu Yang
Overactivated neddylation pathway in human hepatocellular carcinoma. Cancer medicine (2018)